番茄社区app

But Japanese study suggests losses need to be substantial

GLP-1 treatment was tied to lower risks of suicidal ideation, attempts vs lifestyle interventions

Including lipids did not prove superior to non-laboratory-based criteria alone, study finds

Risk of new diabetes diagnosis was higher compared with non-COVID respiratory infections

I anticipate benefits outweighing potential risks in only a select few situations

Bowel preparation protocols appeared protective in small study

Other than staying on drug, there's no evidence-based strategy to maintain weight loss

Nearly 10% of those surveyed reported severe obesity

GLP-1 drugs have the potential to reduce healthcare costs in unexpected ways

Researcher discusses weight outcomes for those taking semaglutide or liraglutide

More noteworthy research from the EASD 2024 meeting

Regulators will need to closely watch this new frontier

But significant weight loss reported for both

Saxenda group six times more likely to lose at least 5% of BMI